RxDoctor Payments Data

Gabrielle Curtis, MD

Family Medicine · Springfield, MONPI 1326076993

Payments from drug & device makers

$761in general payments, 2019–2025

Across 37 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$109
  • Globus Medical$78
  • Otsuka America Pharmaceutical, Inc.$77
  • Protega Pharmaceutials Inc$76
  • Neurocrine Biosciences, Inc.$75
  • Viiv Healthcare Company$68
  • plus $277 from 10 others

What the payments were for

  • Food & beverage$761100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$761 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$1,217
Medicare patients
29
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl59$51,077
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl278$45,203
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen978$33,600
Buprenorphine130$32,742
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen641$20,338
Pregabalin345$12,201
Oxycodone Hcl585$10,910
Naloxone Hcl198$10,806
LinzessLinaclotide11$7,637
Xtampza ErOxycodone Myristate15$6,824
Hysingla ErHydrocodone Bitartrate14$6,030
Gabapentin435$5,959
Varenicline Tartrate33$5,211
Buprenorphine Hcl136$4,596
ButransBuprenorphine11$4,550

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$109$57,90174 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →